KR20080075389A - 락토바실러스 애시도필러스 kcnu - Google Patents
락토바실러스 애시도필러스 kcnu Download PDFInfo
- Publication number
- KR20080075389A KR20080075389A KR1020070014510A KR20070014510A KR20080075389A KR 20080075389 A KR20080075389 A KR 20080075389A KR 1020070014510 A KR1020070014510 A KR 1020070014510A KR 20070014510 A KR20070014510 A KR 20070014510A KR 20080075389 A KR20080075389 A KR 20080075389A
- Authority
- KR
- South Korea
- Prior art keywords
- kcnu
- lactobacillus
- kccm
- ashidophilus
- listeria
- Prior art date
Links
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 70
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 70
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 24
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 15
- 244000005700 microbiome Species 0.000 claims abstract description 14
- 239000003613 bile acid Substances 0.000 claims abstract description 11
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 10
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 claims abstract description 9
- 239000002253 acid Substances 0.000 claims abstract description 9
- 210000000813 small intestine Anatomy 0.000 claims abstract description 9
- 241000588724 Escherichia coli Species 0.000 claims abstract description 6
- 241000193755 Bacillus cereus Species 0.000 claims abstract description 5
- 241000194033 Enterococcus Species 0.000 claims abstract description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 5
- 241000191980 Staphylococcus intermedius Species 0.000 claims abstract description 5
- 241001646719 Escherichia coli O157:H7 Species 0.000 claims abstract description 4
- 241000186781 Listeria Species 0.000 claims abstract description 4
- 241000186779 Listeria monocytogenes Species 0.000 claims abstract description 4
- 238000001179 sorption measurement Methods 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 27
- 235000013305 food Nutrition 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 241000282887 Suidae Species 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000002906 microbiologic effect Effects 0.000 claims description 3
- 241000186805 Listeria innocua Species 0.000 claims description 2
- 241000607768 Shigella Species 0.000 claims description 2
- 241000191940 Staphylococcus Species 0.000 claims 2
- 238000000151 deposition Methods 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 32
- 241000894006 Bacteria Species 0.000 abstract description 19
- 239000004310 lactic acid Substances 0.000 abstract description 16
- 235000014655 lactic acid Nutrition 0.000 abstract description 16
- 239000006041 probiotic Substances 0.000 abstract description 6
- 235000018291 probiotics Nutrition 0.000 abstract description 6
- 244000000010 microbial pathogen Species 0.000 abstract description 4
- 230000000529 probiotic effect Effects 0.000 abstract description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract description 3
- 241000186780 Listeria ivanovii Species 0.000 abstract description 2
- 241000607760 Shigella sonnei Species 0.000 abstract description 2
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 2
- 241000607447 Yersinia enterocolitica Species 0.000 abstract description 2
- 229940115939 shigella sonnei Drugs 0.000 abstract description 2
- 229940098232 yersinia enterocolitica Drugs 0.000 abstract description 2
- 108010062877 Bacteriocins Proteins 0.000 description 18
- 239000002609 medium Substances 0.000 description 13
- 240000001046 Lactobacillus acidophilus Species 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 241000282412 Homo Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 244000199866 Lactobacillus casei Species 0.000 description 6
- 240000006024 Lactobacillus plantarum Species 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 241000178948 Lactococcus sp. Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 241001455523 Escherichia coli O15 Species 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 235000015140 cultured milk Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 239000006872 mrs medium Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 229940050410 gluconate Drugs 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229940017800 lactobacillus casei Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 2
- 101001070790 Homo sapiens Platelet glycoprotein Ib alpha chain Proteins 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 240000002605 Lactobacillus helveticus Species 0.000 description 2
- 241000218587 Lactobacillus paracasei subsp. paracasei Species 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001627205 Leuconostoc sp. Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102100034173 Platelet glycoprotein Ib alpha chain Human genes 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- XBJMQLRJKLDOKY-HKTIBRIUSA-N (2s,3r)-butane-1,2,3,4-tetrol;propane-1,2,3-triol Chemical compound OCC(O)CO.OC[C@H](O)[C@H](O)CO XBJMQLRJKLDOKY-HKTIBRIUSA-N 0.000 description 1
- DKNWDBCFQHXLIC-BNPMENOHSA-N (3s,4s,5r)-1,3,4,5,6-pentahydroxyhexan-2-one;(2s,3s,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C=O.OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO DKNWDBCFQHXLIC-BNPMENOHSA-N 0.000 description 1
- KEQXNNJHMWSZHK-UHFFFAOYSA-L 1,3,2,4$l^{2}-dioxathiaplumbetane 2,2-dioxide Chemical compound [Pb+2].[O-]S([O-])(=O)=O KEQXNNJHMWSZHK-UHFFFAOYSA-L 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- CJIMGHJTKSSCHA-HXCZAFETSA-N C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O.OC[C@H](O)[C@@H](O)[C@H](O)C(=O)CO Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O.OC[C@H](O)[C@@H](O)[C@H](O)C(=O)CO CJIMGHJTKSSCHA-HXCZAFETSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- UXOXDDUEWZOAIW-UHFFFAOYSA-N Inuline Natural products CCN1CC2(CC(=O)Oc3ccccc3N)CCC(OC)C45C6CC7C(CC(O)(C6C7OC)C(O)(C(OC)C24)C15)OC UXOXDDUEWZOAIW-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- 244000126745 Lactobacillus acidophilus 30SC Species 0.000 description 1
- 244000116699 Lactobacillus acidophilus NCFM Species 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000194041 Lactococcus lactis subsp. lactis Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001603151 Philus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- VNRZCPPHNPEBFC-UHFFFAOYSA-N anthranoyllycoctonine Natural products CCN1CC2(COC(=O)c3ccccc3N)CCC(OC)C45C2C(OC)C(O)(C14)C6(O)CC(OC)C7CC5(O)C6C7OC VNRZCPPHNPEBFC-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- DLRVVLDZNNYCBX-LIZSDCNHSA-N beta-D-Glcp-(1->6)-beta-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- BBKFSSMUWOMYPI-UHFFFAOYSA-N gold palladium Chemical compound [Pd].[Au] BBKFSSMUWOMYPI-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- SUSRLLXAXAIZPH-OBPIAQAESA-N hydroquinone beta-D-glucopyranoside Natural products OC[C@H]1O[C@@H](Cc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O SUSRLLXAXAIZPH-OBPIAQAESA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HOVAGTYPODGVJG-VEIUFWFVSA-N methyl alpha-D-mannoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-VEIUFWFVSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229940054441 o-phthalaldehyde Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000013630 prepared media Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Husbandry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
균의 형태 | 막대형 |
집락 색깔 | 유백색 |
생육 최적 온도 | 37℃ |
운동성 | 없음 |
그람염색 | 양성 |
카탈라제 | 음성 |
산소 영향 | 편성 혐기성 |
당 종류 | 이용성 |
Glycerol | - |
Erythritol | - |
D-Arabinose | - |
L-Arabinose | - |
Ribose | - |
D-Xylose | - |
L-Xylose | - |
Adonitol | - |
βMethyl-xyloside | - |
Galactose | + |
D-Glucose | + |
D-Frucose | + |
D-Mannose | + |
L-Sorbose | - |
Rhamnose | - |
Dulcitol | - |
Inositol | + |
Mannitol | - |
Sorbitol | - |
αMethyl-D-mannoside | - |
αMethyl-D-glucosie | - |
N acetyl glucosamine | + |
Amygdaline | + |
Arbutine | - |
Esculin | + |
Salicine | - |
Cellobiose | - |
Maltose | + |
Lactose | + |
Melibiose | + |
Saccharose | + |
Trehalose | - |
Inuline | - |
Melezitose | + |
D-Raffinose | + |
Amidon | + |
Glycogen | - |
Xylitol | - |
βGentiobiose | + |
D-Turanose | + |
D-Lyxose | - |
D-Tagatose | - |
D-Fucose | - |
L-Fucose | + |
D-Arabitol | - |
L-Arabitol | - |
Gluconate | - |
2 ceto-gluconate | - |
5 ceto-gluconate | - |
균종 | 분해율(%) |
락토바실러스 애시도필러스 KCNU | 45.05 |
락토바실러스 애시도필러스 ATCC 4356 | 33.24 |
락토바실러스 애시도필러스 ATCC 43121 | 57.50 |
락토바실러스 애시도필러스 ATCC 4962 | 26.14 |
락토바실러스 델부루엑키 서브스피시스 락티스 ATCC 4797 | 16.26 |
락토바실러스 헬베티쿠스 | 33.43 |
락토바실러스 카제이 911 | 24.75 |
락토바실러스 람노수스 7469 | 25.13 |
박토 프로테오스 펩톤 | 10g |
박토 비프 엑기스 | 10g |
박토 이스트 엑기스 | 5g |
텍스트로스 | 20g |
폴리소르베이트80(or Tween 80) | 1g |
암모니움 시트레이트 | 2g |
소듐 아세테이트 | 5g |
황산마그네슘 | 0.1g |
황산화망간 | 0.05g |
인산화제이칼륨 | 2g |
박토 트립톤 | 17g |
박토 소이톤 | 3g |
텍스트로스 | 2.5g |
염화나트륨 | 5g |
인산화제이칼륨 | 2.5g |
지시균 | 저해여부 |
L. acidophilus 4962 | + |
L. acidophilus GP1B | - |
L. acidophilus 606 | + |
L. acidophilus KU107A | + |
L. acidophilus 30SC | + |
L. acidophilus GP2A | + |
L. acidophilus GP4A | + |
L. acidophilus A4 | - |
L. acidophilus ATCC 4356 | + |
L. acidophilus ATCC 43121 | - |
L. acidophilus NCFM | + |
L. casei 9018 | + |
L. casei 393 | - |
L. casei sp. | + |
L. delbrueckii subsp. lactis ATCC 4797 | + |
L.helveticus 1042 | - |
L. helveticus KU116 | + |
L. paracasei subsp. paracasei 910 | - |
L. paracasei subsp. paracasei 911 | - |
L. plantarum EH2 | + |
L. plantarum CS1 | - |
L. plantarum K 4 | - |
L. plantarum M 2 | - |
L. plantarum B 1 | + |
L. plantarum F7 1 | + |
L. rhamnosus ATCC 7469 | - |
L. lactis subsp. lactis ATCC 11454 | + |
Lactococcus sp. 449 | - |
Lactococcus sp. LN518 | + |
Lactococcus sp. LO518 | + |
Lactococcus sp. HT61 | - |
Lactococcus sp. HT51 | + |
Leuconostoc sp. K2 | - |
Leuconostoc sp. K1 | + |
Pathogens | Strains |
GP1B | |
Acinetobacter baumannii | - |
Bacillus cereus | + |
Bacillus subtilis | - |
Enterococcus aerogenes | + |
Escherichia coli K11234 | - |
Escherichia coli K21052 | + |
Escherichia coli O15:H7 ATCC 43894 | - |
Escherichia coli O15:H7 ATCC 43895 | - |
Escherichia coli O15:H7 ATCC 43889 | + |
Escherichia coli O15:H7 ATCC 43893 | - |
Fecal streptococcus | - |
Klebstella pneumoniae | - |
Listeria inoccua | + |
Listeria monocytogene | + |
Listeria ivanovii | + |
Salmonella typhimurium K11806 | - |
Shigella sonnei | + |
Staphylococcus aureus | + |
Staphylococcus epidermidis KCCM35494 | + |
Staphylococcus intermedius KCCM40149 | + |
Pseudomonas aeruginosa KCCM11321 | + |
Pseudomonas chororaphis K11363 | - |
Pseudomonas fluorescens | - |
Yersinia enterocolitica | + |
정제단계 | Total protein (mg) | Total acivity (AU/ml) | Specific acivity (AU/mg) | Purification fold | Recovery (%) | |
배양액(895ml) | 203.2 | 2,864,000 | 14,094 | 1 | 100 | |
황산 암모늄 농도 | 30% | 1.05 | 35,840 | 34,133 | 2.42 | 1.25 |
30~40% | 14.73 | 1,945,600 | 132,084 | 9.37 | 67.9 | |
40~50% | 11.94 | 53,760 | 4,502 | 0.32 | 1.88 |
Claims (8)
- 유해성 미생물의 생육을 억제하는 기능을 갖는 락토바실러스 애시도필러스 KCNU(기탁기관 : 한국종균협회부설 한국미생물보존센터, 수탁번호 : KCCM-10753P호, 수탁일자 : 2006년 5월 22일).
- 제 1 항에 있어서,상기 락토바실러스 애시도필러스 KCNU는 내산성, 담즙산 내성 및 콜레스테롤 흡착 능력이 있는 것을 특징으로 락토바실러스 애시도필러스 KCNU.
- 제 1 항에 있어서,상기 유해성 미생물은 바실러스 세레우스, 엔테로코커스 에로제네스, 대장균 K21052, 대장균 O157:H7 ATCC 43889, 리스테리아 이노큐아, 리스테리아 모노시토제네스, 리스테리아 이바노비, 쉬겔라 소네이, 스타필로코커스 오레우스, 스타필로코커스 에피더미디스 KCCM 35494, 스타필로코커스 인터메디우스 KCCM 40149, 슈도모나스 에루지노사 KCCM 11363, 엘시니아 엔테로콜리티카 중 어느 하나 이상인 것을 특징으로 하는 락토바실러스 애시도필러스 KCNU.
- 제 1 항에 있어서,상기 락토바실러스 애시도필러스 KCNU는 돼지의 소장으로부터 채취된 것을 특징으로 하는 락토바실러스 애시도필러스 KCNU.
- 제1항의 락토바실러스 애시도필러스 KCNU 또는 그 배양물을 포함하는 것을 특징으로 하는 약품 조성물.
- 제1항의 락토바실러스 애시도필러스 KCNU 또는 그 배양물을 포함하는 것을 특징으로 하는 식품 조성물.
- 제1항의 락토바실러스 애시도필러스 KCNU 또는 그 배양물을 포함하는 것을 특징으로 하는 사료용 조성물.
- 제1항의 락토바실러스 애시도필러스 KCNU 또는 그 배양물을 포함하는 것을 특징으로 하는 항균 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070014510A KR100871904B1 (ko) | 2007-02-12 | 2007-02-12 | 락토바실러스 애시도필러스 kcnu |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070014510A KR100871904B1 (ko) | 2007-02-12 | 2007-02-12 | 락토바실러스 애시도필러스 kcnu |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080075389A true KR20080075389A (ko) | 2008-08-18 |
KR100871904B1 KR100871904B1 (ko) | 2008-12-05 |
Family
ID=39879045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070014510A KR100871904B1 (ko) | 2007-02-12 | 2007-02-12 | 락토바실러스 애시도필러스 kcnu |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100871904B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3022256A1 (fr) * | 2014-06-17 | 2015-12-18 | Adisseo France Sas | Nouvelles souches d’arthrobacter gandavensis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990007711A (ko) * | 1998-10-22 | 1999-01-25 | 이용규 | 항 콜레스테롤 유산균을 이용한 기능성 발효유 제조 방법 |
KR100523256B1 (ko) * | 2002-02-23 | 2005-10-24 | 주식회사 프로바이오닉 | 결장 암 세포 및 유해 미생물 증식 억제 활성과 장내정착력이 뛰어난 신규 내산성 락토바실러스 애시도필러스 Probio-40 |
TWI241912B (en) | 2002-10-30 | 2005-10-21 | Food Industry Res & Dev Inst | Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
KR20080003637A (ko) * | 2006-07-03 | 2008-01-08 | 한상기 | 다이어트효과가 우수한 기능성 유산균발효조성물 |
-
2007
- 2007-02-12 KR KR1020070014510A patent/KR100871904B1/ko active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3022256A1 (fr) * | 2014-06-17 | 2015-12-18 | Adisseo France Sas | Nouvelles souches d’arthrobacter gandavensis |
WO2015193618A1 (fr) * | 2014-06-17 | 2015-12-23 | Adisseo France S.A.S. | Nouvelles souches d'arthrobacter gandavensis |
US10357047B2 (en) | 2014-06-17 | 2019-07-23 | Adisseo France S.A.S. | Arthrobacter gandavensis strains |
Also Published As
Publication number | Publication date |
---|---|
KR100871904B1 (ko) | 2008-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Oh et al. | Characterization and purification of a bacteriocin produced by a potential probiotic culture, Lactobacillus acidophilus 30SC | |
Wu et al. | Isolation and preliminary probiotic selection of lactobacilli from koumiss in Inner Mongolia | |
US7241441B2 (en) | Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities | |
US20080267932A1 (en) | Lactobacillus Rhamnosus with Body-Fat Reducing Activity and the Foods Containing Them | |
US20040038379A1 (en) | Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom | |
EP1743042B1 (en) | Lactic acid bacteria strains exhibiting probiotic properties and compositions comprising the same | |
Aslam et al. | Isolation of acidophilic lactic acid bacteria antagonistic to microbial contaminants | |
KR20190063795A (ko) | 락토바실러스 플란타룸 mifi-sy3 균주를 이용한 아로니아 발효액의 제조방법 | |
KR100707102B1 (ko) | 헬리코박터 파이로리 및 유해미생물의 증식을 억제하는 김치 유산균, 이를 이용한 김치의 제조방법 및 이의 용도 | |
KR101834231B1 (ko) | 신선유지를 위한 항균 및 항진균 활성을 갖는 식물성 유산균 락토바실러스 플란타륨 dsr kf15 및 이의 용도 | |
KR100864006B1 (ko) | 김치로부터 분리된 유산균 및 그의 용도 | |
KR20030064030A (ko) | 위액 및 담즙산에 대한 내성이 높아 장내 생존력이 우수한한국인 분변 유래 유용 프로바이오틱 생균 및 그의 용도 | |
KR100871904B1 (ko) | 락토바실러스 애시도필러스 kcnu | |
KR101302465B1 (ko) | 김치로부터 분리된 유산균 및 상기 유산균을 이용한 발효식품 | |
KR101696670B1 (ko) | 내산성, 내담즙성 및 세포 부착능이 우수한 락토바실러스 플랜타럼 llp5193, 및 이를 유효성분으로 포함하는 제품 | |
KR100434610B1 (ko) | 락토바실러스 애시도필러스 30sc | |
Bae et al. | Probiotic Characterization of Acid-and Bile-tolerant Lactobacillus salivarius subsp. salivarius from Korean Faeces | |
KR20020088797A (ko) | 알콜에 내성있는 신규한 유용 프로바이오틱 생균 및 그의용도 | |
KR100715730B1 (ko) | 유해 병원성 미생물에 대한 항균활성을 갖는 신규비피도박테리움 롱검 a24 | |
KR100354315B1 (ko) | 신규한 항균성 물질을 생산하는 락토바실러스 속 미생물 | |
Nardi et al. | Antagonism against anaerobic and facultative bacteria through a diffusible inhibitory compound produced by a Lactobacillus sp. isolated from the rat fecal microbiota | |
KR101780770B1 (ko) | 한국 전통 간장에서 분리된 신규 바실러스 균주 및 이를 함유하는 프로바이오틱스 | |
KR100808956B1 (ko) | 김치로부터 분리된 유산균 및 이로부터 얻어지는 엑소폴리사카라이드 | |
JPH05236945A (ja) | 新規ラクトバチルス属微生物 | |
Abiona et al. | Molecular characteristics of probiotics lactic acid bacteria isolated from soursop, cowmilk, goatmilk yoghurts and cheese |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121122 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20131108 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141127 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151029 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20171102 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20181023 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20191112 Year of fee payment: 12 |